| Gene symbol | CLDN18 | Synonyms | SFTA5, SFTPJ | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3q22.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | claudin 18 | ||||
| GTO ID | GTC2738 |
| Trial ID | NCT04977193 |
| Disease | Gastric Adenocarcinoma |
| Altered gene | CLDN18 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | LY011 |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | A Study to Evaluate the Safety and Efficacy of ly011 Cell Injection in the Treatment of Advanced Gastric Adenocarcinoma |
| Year | 2021 |
| Country | China |
| Company sponsor | Shanghai Longyao Biotechnology Inc., Ltd. |
| Other ID(s) | LY011C1002 |
| Cohort 1 | |||||||
|
|||||||